Alexander Shimabukuro-Vornhagen
Alexander Shimabukuro-Vornhagen
Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany
Verified email at
Cited by
Cited by
Cytokine release syndrome
A Shimabukuro-Vornhagen, P Gödel, M Subklewe, HJ Stemmler, ...
Journal for immunotherapy of cancer 6, 1-14, 2018
COVID‐19 associated pulmonary aspergillosis
P Koehler, OA Cornely, BW Böttiger, F Dusse, DA Eichenauer, F Fuchs, ...
Mycoses 63 (6), 528-534, 2020
The role of B cells in the pathogenesis of graft-versus-host disease
A Shimabukuro-Vornhagen, MJ Hallek, RF Storb, ...
Blood, The Journal of the American Society of Hematology 114 (24), 4919-4927, 2009
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
FX Lescure, H Honda, RA Fowler, JS Lazar, G Shi, P Wung, N Patel, ...
The Lancet Respiratory Medicine 9 (5), 522-532, 2021
Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials
A Shimabukuro-Vornhagen, H Haverkamp, A Engert, L Balleisen, ...
J Clin Oncol 23 (24), 5739-45, 2005
Characterization of tumor-associated B-cell subsets in patients with colorectal cancer
A Shimabukuro-Vornhagen, HA Schlößer, L Gryschok, J Malcher, ...
Oncotarget 5 (13), 4651, 2014
Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma
A Lechner, H Schlößer, SI Rothschild, M Thelen, S Reuter, P Zentis, ...
Oncotarget 8 (27), 44418, 2017
Critical care of patients with cancer
A Shimabukuro‐Vornhagen, B Boell, M Kochanek, E Azoulay, ...
CA: a cancer journal for clinicians 66 (6), 496-517, 2016
Tumor-associated B cells and humoral immune response in head and neck squamous cell carcinoma
A Lechner, HA Schlößer, M Thelen, K Wennhold, SI Rothschild, R Gilles, ...
Oncoimmunology 8 (3), 1535293, 2019
Functional activity of natural antibody is altered in Cr2-deficient mice
RR Reid, S Woodcock, A Shimabukuro-Vornhagen, WG Austen, L Kobzik, ...
The Journal of Immunology 169 (10), 5433-5440, 2002
Physical exercise modulates the homeostasis of human regulatory T cells
M Weinhold, A Shimabukuro-Vornhagen, A Franke, S Theurich, P Wahl, ...
Journal of Allergy and Clinical Immunology 137 (5), 1607-1610. e8, 2016
In the eye of the storm: immune-mediated toxicities associated with CAR-T cell therapy
JG Borrega, P Gödel, MA Rüger, ÖA Onur, A Shimabukuro-Vornhagen, ...
Hemasphere 3 (2), e191, 2019
Comparison of bone marrow versus peripheral blood allogeneic hematopoietic stem cell transplantation for hematological malignancies in adults—a systematic review and meta-analysis
U Holtick, M Albrecht, JM Chemnitz, S Theurich, ...
Critical reviews in oncology/hematology 94 (2), 179-188, 2015
CD40-activated B cells express full lymph node homing triad and induce T-cell chemotaxis: potential as cellular adjuvants
M von Bergwelt-Baildon, A Shimabukuro-Vornhagen, A Popov, ...
Blood 107 (7), 2786-2789, 2006
Brentuximab vedotin combined with donor lymphocyte infusions for early relapse of Hodgkin lymphoma after allogeneic stem-cell transplantation induces tumor-specific immunity …
S Theurich, J Malcher, K Wennhold, A Shimabukuro-Vornhagen, ...
Journal of clinical oncology: official journal of the American Society of …, 2013
B cell-based cancer immunotherapy
K Wennhold, A Shimabukuro-Vornhagen, M von Bergwelt-Baildon
Transfusion Medicine and Hemotherapy 46 (1), 36-46, 2019
Intensive care management of influenza-associated pulmonary aspergillosis
P Koehler, M Bassetti, M Kochanek, A Shimabukuro-Vornhagen, ...
Clinical Microbiology and Infection 25 (12), 1501-1509, 2019
Long-term (180-day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial
S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, A Kidwai, ...
Jama 329 (1), 39-51, 2023
Consensus statement for cancer patients requiring intensive care support
MG Kiehl, G Beutel, B Böll, D Buchheidt, R Forkert, V Fuhrmann, P Knöbl, ...
Annals of hematology 97, 1271-1282, 2018
OCTET‐CY: a phase II study to investigate the efficacy of post‐transplant cyclophosphamide as sole graft‐versus‐host prophylaxis after allogeneic peripheral blood stem cell …
U Holtick, JM Chemnitz, A Shimabukuro‐Vornhagen, S Theurich, ...
European journal of haematology 96 (1), 27-35, 2016
The system can't perform the operation now. Try again later.
Articles 1–20